|
|
|
|
|
Latest Filings
|
| View
|
Form
|
|
Filer
|
Received
|
Period
|
Download / Print
|
Actions
|
    |
SC 13D/A |
|
FORTRESS BIOTECH, INC. |
04/02/25 |
|
|
|
  |
 |
4 |
|
FORTRESS BIOTECH, INC. |
04/02/25 |
03/31/25 |
|
|
|
  |
10-K |
|
AVENUE THERAPEUTICS, INC. |
03/31/25 |
12/31/24 |
|
|
|
| |
8-K |
|
AVENUE THERAPEUTICS, INC. |
03/17/25 |
03/17/25 |
|
|
|
| |
8-K |
|
AVENUE THERAPEUTICS, INC. |
03/07/25 |
03/07/25 |
|
|
|
| |
SC 13G/A |
|
ARMISTICE CAPITAL, LLC |
02/14/25 |
|
|
|
|
| |
SC 13G |
|
IKARIAN CAPITAL, LLC |
02/14/25 |
|
|
|
|
| |
SC 13D/A |
|
FORTRESS BIOTECH, INC. |
01/03/25 |
|
|
|
|
| |
3 |
|
FORTRESS BIOTECH, INC. |
01/03/25 |
12/31/24 |
|
|
|
| |
S-3 |
|
AVENUE THERAPEUTICS, INC. |
12/04/24 |
|
|
|
|
|
|
|
|
|
Institutional Holders
|
|
|
Total Number of Holders
|
12
|
|
% of Shares Outstanding |
6.12%
|
|
Total Shares Held |
192,636
|
|
Total Value of Holdings |
$48,159.00
|
|
Net Activity |
(4,886)
|
|
|
|
|
|
|
|
Latest Company News
|
|
Date
|
|
|
|
|
|
|
(Quotes provided by Thomson Reuters are delayed by
15
minutes or more.)
|
|